Inventor · disambiguated record
Ginette Serrero
Also filed as: SERRERO GINETTE
25 granted patents·11 pending applications·306 citations·filing 1991–2023
96Inventor score
Top patents by PatentIndex Score
36 records- 0190US7815906B2Compositions and methods for restoring sensitivity to treatment with HER2 antagonistsA & G PHARMACEUTICAL INC·Filed 2008·Granted Oct 19, 2010·12 cites·32 claims
- 0289US7368428B2Compositions and methods for restoring sensitivity of tumor cells to antitumor therapy and inducing apoptosisA & G PHARMACEUTICAL INC·Filed 2004·Granted May 6, 2008·32 cites·7 claims
- 0386US7091047B2Methods and kits for diagnosing tumorigenicityA & G PHARMACEUTICAL INC·Filed 2002·Granted Aug 15, 2006·19 cites·37 claims
- 0486US6824775B288kDa tumorigenic growth factor and antagonistsA & G PHARMACEUTICAL INC·Filed 2001·Granted Nov 30, 2004·9 cites·42 claims
- 0584US7674460B2Compositions and methods for restoring sensitivity to treatment with HER2 antagonistsA & G PHARMACEUTICAL INC·Filed 2004·Granted Mar 9, 2010·18 cites·6 claims
- 0684US7411045B2Autocrine growth factor receptor antibodies and methodsA & G PHARMACEUTICAL INC·Filed 2002·Granted Aug 12, 2008·14 cites·24 claims
- 0783US6309826B188kDa tumorigenic growth factor and antagonistsFiled 1997·Granted Oct 30, 2001·33 cites·36 claims
- 0882US5723115AInhibition of adipose tissue development and obesityALTON JONES CELL SCIENCE CENTE·Filed 1993·Granted Mar 3, 1998·51 cites·11 claims
- 0981US6670183B288kDa tumorigenic growth factor and antagonistsA & G PHARMACEUTICAL INC·Filed 2001·Granted Dec 30, 2003·11 cites·10 claims
- 1080US11555074B2Monoclonal antibodies and conjugates against prostaglandin F2 receptor inhibitor and uses thereofA&G PHARMACEUTICAL INC·Filed 2018·Granted Jan 17, 2023·1 cites·15 claims
- 1180US6881548B2Methods and kits for diagnosing tumorigenicity and determining resistance to the antineoplastic effects of antiestrogen therapyA & G PHARMACEUTICAL INC·Filed 2001·Granted Apr 19, 2005·14 cites·22 claims
- 1277US8007997B2Methods and compositions for inhibiting the growth of hematopoietic malignant cellsA & G PHARMACEUTICAL INC·Filed 2009·Granted Aug 30, 2011·0 cites·6 claims
- 1375US7592318B288kDa tumorigenic growth factor and antagonistsA & G PHARMACEUTICAL INC·Filed 2003·Granted Sep 22, 2009·3 cites·11 claims
- 1474US5449757AMammalian adipogenic factorsALTON JONES CELL SCIENCE CENTE·Filed 1994·Granted Sep 12, 1995·28 cites·15 claims
- 1573US8512960B288kDa tumorigenic growth factor and antagonistsSERRERO GINETTE·Filed 2008·Granted Aug 20, 2013·1 cites·14 claims
- 1671US2024199738A1Monoclonal antibodies and conjugates against prostaglandin f2 receptor inhibitor and uses thereofA & G PHARMACEUTICAL INC·Filed 2022·Application pending·0 cites
- 1770US6720159B188KDA tumorigenic growth factor and antagonistsA & G PHARMACEUTICAL INC·Filed 1999·Granted Apr 13, 2004·14 cites·35 claims
- 1867US5268295AMammalian adipocyte protein p154, nucleic acids coding therefor and uses thereofALTON JONES CELL SCIENCE CENTE·Filed 1991·Granted Dec 7, 1993·27 cites·12 claims
- 1967US2008114070A1Compositions and methods for restoring sensitivity of tumor cells to antitumor therapy and inducing apoptosisA & G PHARMACEUTICAL INC·Filed 2008·Application pending·0 cites
- 2063US2025154237A1Fully human monoclonal antibodies against human progranulinA & G PHARMACEUTICAL INC·Filed 2023·Application pending·0 cites
- 2162US8088373B2Autocrine growth factor receptor antibodies and methodsSERRERO GINETTE·Filed 2008·Granted Jan 3, 2012·0 cites·16 claims
- 2260US2003215445A1Methods and compositions for inhibiting the growth of hematopoietic malignant cellsFiled 2002·Application pending·0 cites
- 2359US7651854B2Methods for increasing the proliferation of B cellsA & G PHARMACEUTICAL INC·Filed 2003·Granted Jan 26, 2010·0 cites·8 claims
- 2459US2011223623A1Methods for diagnosing cancer and determining the overall survival and disease-free survival of cancer patientsA & G PHARMACEUTICAL INC·Filed 2009·Application pending·0 cites
- 2559US2003092661A188kDa tumorigenic growth factor and antagonistsFiled 2002·Application pending·0 cites
- 2658US8911950B2Methods and compositions for inhibiting the growth of hematopoietic malignant cellsSERRERO GINETTE·Filed 2011·Granted Dec 16, 2014·0 cites·5 claims
- 2757US5846734AMammalian adipogenic factorsALTON JONES CELL SCIENCE CENTE·Filed 1995·Granted Dec 8, 1998·7 cites·2 claims
- 2856US7183384B2Monoclonal antibody 7H11 reactive with human cancerA & G PHARMACEUTICAL INC·Filed 2004·Granted Feb 27, 2007·4 cites·8 claims
- 2956US2016274114A1Methods for diagnosing cancer and determining the overall survival and disease-free survival of cancer patientsA&G PHARMACEUTICAL INC·Filed 2016·Application pending·0 cites
- 3056US2011053182A1Diagnosis of pre-cancerous conditions using pcdgf agentsKINCH MICHAEL S·Filed 2009·Application pending·0 cites
- 3152US7560095B2Cancer specific monoclonal antibodiesA & G PHARMACEUTICAL INC·Filed 2004·Granted Jul 14, 2009·0 cites·12 claims
- 3252US2010111928A1Methods and kits for diagnosis tumorgenicityA & G PHARMACEUTICAL INC·Filed 2008·Application pending·0 cites
- 3345US2006210568A1Methods and compositions for cancer treatmentSERRERO GINETTE·Filed 2004·Application pending·0 cites
- 3444US5541068AMammalian adipocyte protein P154, nucleic acids coding therefor and uses thereofALTON JONES CELL SCIENCE CENTE·Filed 1993·Granted Jul 30, 1996·5 cites·23 claims
- 3541US2008145369A1Autocrine Growth Factor Receptors and MethodsSERRERO GINETTE·Filed 2005·Application pending·0 cites
- 3639US5817769AAntibodies to mammalian adipogenic factorsALTON JONES CELL SCIENCE CENTE·Filed 1995·Granted Oct 6, 1998·3 cites·2 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →